Search Results - "SAIF, M. Wasif"
-
1
Pharmacokinetically Guided Dose Adjustment of 5-Fluorouracil: A Rational Approach to Improving Therapeutic Outcomes
Published in JNCI : Journal of the National Cancer Institute (18-11-2009)“…Chemotherapy dosing of the fluoropyrimidine 5-fluorouracil (5-FU) is currently based on body surface area. However, body surface area–based dosing has been…”
Get full text
Journal Article -
2
Safety and Efficacy of Oxaliplatin and Fluoropyrimidine Regimens With or Without Bevacizumab As First-Line Treatment of Metastatic Colorectal Cancer: Results of the TREE Study
Published in Journal of clinical oncology (20-07-2008)“…To evaluate the safety and efficacy of three oxaliplatin and fluoropyrimidine regimens, with or without bevacizumab, as first-line treatment for metastatic…”
Get full text
Journal Article -
3
The Role of Src in Colon Cancer and Its Therapeutic Implications
Published in Clinical colorectal cancer (01-03-2014)“…Abstract Src is a member of a superfamily of membrane-associated nonreceptor protein tyrosine kinases. It is stimulated by receptors of growth hormone,…”
Get full text
Journal Article -
4
The role of mTOR in the management of solid tumors: An overview
Published in Cancer treatment reviews (01-04-2009)“…Summary Mammalian target of rapamycin (mTOR) is a key protein kinase controlling signal transduction from various growth factors and upstream proteins to the…”
Get full text
Journal Article -
5
Neoadjuvant therapy for pancreatic cancer: an ongoing debate
Published in Therapeutic advances in gastroenterology (01-07-2016)Get full text
Journal Article -
6
Small cell carcinoma of the colon arising in a carcinoid tumor
Published in Anticancer research (01-04-2013)“…Small cell carcinomas of the gastrointestinal tract are rare and clinically aggressive tumors. A case is presented of a 70 year-old woman who presented with…”
Get full text
Journal Article -
7
Adenocarcinoma ex goblet cell carcinoid in a renal transplant patient: a case report and review of the literature
Published in Anticancer research (01-04-2013)“…Adenocarcinoma ex goblet cell carcinoid is a rare neoplasm of appendiceal origin that contains features of both carcinoid tumor and adenocarcinoma. We report…”
Get full text
Journal Article -
8
Gastric cancer and trastuzumab: first biologic therapy in gastric cancer
Published in Therapeutic Advances in Medical Oncology (01-03-2013)“…Gastric cancer remains difficult to cure and has a poor overall prognosis. Chemotherapy and multimodality therapy has shown some benefit in the treatment of…”
Get full text
Book Review Journal Article -
9
Phase I/II Study of PHY906/Capecitabine in Advanced Hepatocellular Carcinoma
Published in Anticancer research (01-10-2009)“…PHY906 is a Chinese medicine formula with claims for the treatment of severe gastrointestinal distress. PHY906 enhanced the therapeutic index of various…”
Get full text
Journal Article -
10
Does erlotinib restore chemosensitivity to chemotherapy in pancreatic cancer? A case series
Published in Anticancer research (01-03-2011)“…Erlotinib (Tarceva) in combination with gemcitabine is indicated for first-line treatment of patients with locally advanced, unresectable or metastatic…”
Get full text
Journal Article -
11
Phase II study of intravenous TZT‐1027 in patients with advanced or metastatic soft‐tissue sarcomas with prior exposure to anthracycline‐based chemotherapy
Published in Cancer (15-12-2006)“…BACKGROUND. TZT‐1027, a novel chemotherapeutic agent, is derived from dolastatin 10, and blocks cells during G2/M‐phase by interfering with microtubule…”
Get full text
Journal Article -
12
PET scanning: worth the cost in cancer? Not for all cancers--it's not reliable enough yet
Published in Oncology (Williston Park, N.Y.) (01-05-2014)Get more information
Journal Article -
13
Secondary pancreatic involvement by a diffuse large B-cell lymphoma presenting as acute pancreatitis
Published in World journal of gastroenterology : WJG (28-09-2007)“…Diffuse large B-cell lymphoma is the most common type of non-Hodgkin's lymphoma. More than 50% of patients have some site of extra-nodal involvement at…”
Get full text
Journal Article -
14
A Phase I/II Open-Label Multicenter Single-Arm Study of FABLOx (Metronomic 5-Fluorouracil Plus nab -Paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin) in Patients with Metastatic Pancreatic Cancer
Published in Journal of pancreatic cancer (01-09-2019)“…Purpose: To evaluate safety and preliminary efficacy of metronomic 5-fluorouracil plus nab-paclitaxel, bevacizumab, leucovorin, and oxaliplatin (FABLOx) in…”
Get full text
Journal Article -
15
Phase I Study of Capecitabine With Concomitant Radiotherapy for Patients With Locally Advanced Pancreatic Cancer: Expression Analysis of Genes Related to Outcome
Published in Journal of clinical oncology (01-12-2005)“…To establish the feasibility of capecitabine with concurrent radiotherapy (XRT) in patients with locally advanced (LA) pancreatic cancer and evaluate the…”
Get full text
Journal Article Conference Proceeding -
16
Primary Peritoneal Carcinoma in Complete Remission: a Case Report
Published in Anticancer research (01-12-2011)“…Primary peritoneal carcinoma (PPCa) is a relatively uncommonly diagnosed tumor. It has a similar presentation to ovarian cancer. PPCa has a poor prognosis with…”
Get full text
Journal Article -
17
Bolus 5-Fluorouracil as an Alternative Modality to Infusion 5-Fluorouracil in a Patient with Rectal Cancer and Capecitabine-induced Cardiotoxicity
Published in In vivo (Athens) (01-09-2009)“…5-Fluorouracil (5-FU) is the backbone of the chemotherapy regimens approved for treatment of colorectal cancer. Incidence of cardiotoxicity associated with…”
Get full text
Journal Article -
18
Erlotinib: the first biologic in the management of pancreatic cancer
Published in Expert opinion on pharmacotherapy (01-06-2008)“…Pancreatic cancer remains a major therapeutic challenge largely characterized by chemotherapy-refractory disease and poor responses to currently available…”
Get more information
Journal Article -
19
Safety and Efficacy of Everolimus in Adult Patients with Neuroendocrine Tumors
Published in Clinical Medicine Insights. Oncology (01-01-2012)“…Neuroendocrine tumors (NETs) consist of a diverse family of tumors which are derived from the neuroendocrine system. Most NETs are well or moderately…”
Get full text
Journal Article Book Review -
20
An Adverse Interaction Between Warfarin and Fluoropyrimidines Revisited
Published in Clinical colorectal cancer (01-09-2005)“…Regimens based on flouropyrimidines (eg, 5-fluorouracil [5-FU] and capecitabine) are the mainstay of chemotherapy for several malignancies, including colon,…”
Get full text
Journal Article